SS
EWTX icon

SBI Securities’s Edgewise Therapeutics EWTX Stock Holding History

SBI Securities’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.37K Hold
206
– – ﹤0.01% 1929
2026
Q1 		$6.49K Sell
206
-1
-0.5% -$29 ﹤0.01% 1913
2025
Q4 		$5.14K Hold
207
– – ﹤0.01% 2009
2025
Q3 		$3.36K Hold
207
– – ﹤0.01% 2223
2025
Q2 		$2.71K Sell
207
-36
-15% -$519 ﹤0.01% 2264
2025
Q1 		$5.35K Hold
243
– – ﹤0.01% 1870
2024
Q4 		$6.49K Buy
+243
New +$7.74K ﹤0.01% 1822

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities's EWTX Position: Q2 2026 in Review

SBI Securities held its Edgewise Therapeutics (EWTX) position steady in Q2 2026 at 206 shares worth $8.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1929.

SBI Securities first reported a position in EWTX in Q4 2024 and has held it in 7 quarters since. 225 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • SBI Securities held 206 shares of Edgewise Therapeutics worth $8.37K as of Q2 2026.
  • SBI Securities left its Edgewise Therapeutics share count unchanged in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1929 holding.
  • SBI Securities first reported a position in Edgewise Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 225 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.